Iterum Therapeutics plc
ITRM
$0.42
$0.000.77%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 11.00M | 13.03M | 12.65M | 24.13M | 14.50M |
| Total Receivables | 546.00K | 80.00K | 19.00K | 66.00K | 274.00K |
| Inventory | 1.15M | 948.00K | 533.00K | -- | -- |
| Prepaid Expenses | 1.03M | 836.00K | 290.00K | 531.00K | 814.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 19.00K | 65.00K | 264.00K |
| Total Current Assets | 13.73M | 14.89M | 13.51M | 24.79M | 15.85M |
|
|
|||||
| Total Current Assets | 13.73M | 14.89M | 13.51M | 24.79M | 15.85M |
| Net Property, Plant & Equipment | 18.00K | 12.00K | 18.00K | 23.00K | 30.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 18.71M | 19.06M | 19.40M | 19.75M | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 48.00K | 53.00K | 40.00K | 39.00K | 40.00K |
| Total Assets | 32.50M | 34.01M | 32.98M | 44.60M | 15.92M |
|
|
|||||
| Total Accounts Payable | 577.00K | 1.19M | 413.00K | 251.00K | 835.00K |
| Total Accrued Expenses | 5.22M | 3.95M | 2.88M | 2.65M | 3.49M |
| Short-term Debt | -- | -- | -- | 14.46M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 281.00K | 190.00K | 144.00K | 67.00K | 13.98M |
| Total Finance Division Other Current Liabilities | 356.00K | 203.00K | 193.00K | 173.00K | 400.00K |
| Total Other Current Liabilities | 356.00K | 203.00K | 193.00K | 173.00K | 400.00K |
| Total Current Liabilities | 6.43M | 5.53M | 3.63M | 17.61M | 18.70M |
|
|
|||||
| Total Current Liabilities | 6.43M | 5.53M | 3.63M | 17.61M | 18.70M |
| Long-Term Debt | 33.45M | 32.37M | 31.90M | 31.07M | 8.73M |
| Short-term Debt | -- | -- | -- | 14.46M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 39.88M | 37.90M | 35.53M | 48.68M | 27.43M |
|
|
|||||
| Common Stock & APIC | 499.07M | 493.59M | 488.41M | 481.99M | 467.98M |
| Retained Earnings | -506.45M | -497.47M | -490.96M | -486.07M | -479.49M |
| Treasury Stock & Other | -- | -- | -- | -- | 2.00K |
| Total Common Equity | -7.38M | -3.89M | -2.55M | -4.08M | -11.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.38M | -3.89M | -2.55M | -4.08M | -11.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.38M | -3.89M | -2.55M | -4.08M | -11.51M |
|
|
|||||